|
PARS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.03999999945259E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.83270000023661E-07 |
| Normal-vs-Stage2 |
8.173500E-02 |
| Normal-vs-Stage3 |
1.378790E-01 |
| Normal-vs-Stage4 |
8.470300E-02 |
| Stage1-vs-Stage2 |
7.790600E-01 |
| Stage1-vs-Stage3 |
2.465400E-01 |
| Stage1-vs-Stage4 |
7.171800E-01 |
| Stage2-vs-Stage3 |
6.072800E-01 |
| Stage2-vs-Stage4 |
9.157400E-01 |
| Stage3-vs-Stage4 |
7.276200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.8501000044231E-08 |
| Normal-vs-AfricanAmerican |
1.603300E-03 |
| Normal-vs-Asian |
8.795200E-01 |
| Caucasian-vs-AfricanAmerican |
1.379160E-01 |
| Caucasian-vs-Asian |
2.117600E-01 |
| AfricanAmerican-vs-Asian |
3.220800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.67450000321656E-08 |
| Normal-vs-Female |
1.644900E-03 |
| Male-vs-Female |
2.763400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.476800E-03 |
| Normal-vs-Extreme_Weight |
1.236670E-04 |
| Normal-vs-Obese |
1.784900E-03 |
| Normal-vs-Extreme_Obese |
2.788200E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.717400E-01 |
| Normal_Weight-vs-Obese |
9.272200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.546240E-01 |
| Extreme_Weight-vs-Obese |
7.149400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.012400E-01 |
| Obese-vs-Extreme_Obese |
1.516990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.580200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.33219999998158E-06 |
| Normal-vs-Age(61-80Yrs) |
2.69890000004214E-06 |
| Normal-vs-Age(81-100Yrs) |
6.097000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.987000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.853400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.974000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.582400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.985900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.348160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.16989973264481E-10 |
| Normal-VS-Type2 PRCC |
3.004000E-02 |
| Normal-VS-KIRP CIMP |
9.661800E-01 |
| Normal-VS-Unclassified PRCC |
4.844500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.604600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.088460E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.437200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.366000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.848800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.028640E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.538300E-02 |
| Normal-vs-N1 |
1.142760E-01 |
| Normal-vs-N2 |
9.777800E-01 |
| N0-vs-N1 |
8.226000E-01 |
| N0-vs-N2 |
4.639000E-01 |
| N1-vs-N2 |
5.247800E-01 |
|
|
